Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion

被引:18
作者
Bahi, Amine
Boyer, Frederic
Kafri, Tal
Dreyer, Jean-Luc
机构
[1] Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland
[2] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
关键词
addiction; in vivo gene transfer; lentivirus; plasticity; small interfering RNA; urokinase-type plasminogen activator;
D O I
10.1111/j.1471-4159.2006.04013.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serine proteases in the nervous system have functional roles in neural plasticity. Among them, urokinase-type plasminogen activator (uPA) exerts a variety of functions during development, and is involved in learning and memory. Furthermore, psychostimulants strongly induce uPA expression in the mesolimbic dopaminergic pathway. In this study, doxycycline-regulatable lentiviruses expressing either uPA, a dominant-negative form of uPA, or non-regulatable lentiviruses expressing small interfering RNAs (siRNAs) targeted against uPA have been prepared and injected into the ventral tegmental area (VTA) of rat brains. Over-expression of uPA in the VTA induces doxycycline-dependent expression of its receptor, uPAR, but not its inhibitor, plasminogen activator inhibitor-1 (PAI-1). uPAR expression in the VTA is repressed upon silencing of uPA with lentiviruses expressing siRNAs. In addition, over-expression of uPA in the VTA promotes a 15-fold increase in locomotion activity upon cocaine delivery. Animals expressing the dominant-negative form of uPA did not display such hyperlocomotor activity. These cocaine-induced behavioural changes, associated with uPA expression, could be suppressed in the presence of doxycycline or uPA-specific siRNAs expressing lentiviruses. These data strongly support the major role of urokinase in cocaine-mediated plasticity changes.
引用
收藏
页码:1619 / 1631
页数:13
相关论文
共 67 条
[1]   Induction of nuclear factor-κB in nucleus accumbens by chronic cocaine administration [J].
Ang, E ;
Chen, JS ;
Zagouras, P ;
Magna, H ;
Holland, J ;
Schaeffer, E ;
Nestler, EJ .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (01) :221-224
[2]   Silencing dopamine D3-receptors in the nucleus accumbens shell in vivo induces changes in cocaine-induced hyperlocomotion [J].
Bahi, A ;
Boyer, F ;
Bussard, G ;
Dreyer, JL .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (12) :3415-3426
[3]   In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour [J].
Bahi, A ;
Boyer, F ;
Kolira, M ;
Dreyer, JL .
JOURNAL OF NEUROCHEMISTRY, 2005, 92 (05) :1243-1255
[4]   In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administration [J].
Bahi, A ;
Boyer, F ;
Gumy, C ;
Kafri, T ;
Dreyer, JL .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (12) :3473-3488
[5]   CD81-induced behavioural changes during chronic cocaine administration:: in vivo gene delivery with regulatable lentivirus [J].
Bahi, A ;
Boyer, F ;
Kafri, T ;
Dreyer, JL .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (06) :1621-1633
[6]  
Bednarski E, 1997, J NEUROSCI, V17, P4006
[7]   CA2+ INFLUX AND NEURITE GROWTH IN RESPONSE TO PURIFIED N-CADHERIN AND LAMININ [J].
BIXBY, JL ;
GRUNWALD, GB ;
BOOKMAN, RJ .
JOURNAL OF CELL BIOLOGY, 1994, 127 (05) :1461-1475
[8]   Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory [J].
Calabresi, P ;
Napolitano, M ;
Centonze, D ;
Marfia, GA ;
Gubellini, P ;
Teule, MA ;
Berretta, N ;
Bernardi, G ;
Frati, L ;
Tolu, M ;
Gulino, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (03) :1002-1012
[9]   Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer [J].
de Bock, CE ;
Wang, Y .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :13-39
[10]   Localization of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse forebrain during postnatal development [J].
Del Bigio, MR ;
Hosain, S ;
Altumbabic, M .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1999, 17 (04) :387-399